Commercial leaders vs. other companies in U.S. biotech 2010-2011 (fee-based)

Reading support:
This statistic depicts a comparison of commercial leaders vs. other companies in U.S. biotechnology in 2010 and 2011. In 2010, the revenues of commercial leaders amounted to 50.3 billion U.S. dollars, while the revenues of other companies in this sector came to some 10.8 billion U.S. dollars.